Ann Samnegård

2.0k citations

27 papers · 1.5k indexed · h-index 22

Immunology top 5%
Epidemiology top 10%
Molecular Biology
Cardiology and Cardiovascular Medicine top 5%
Cancer Research top 10%

Co-authors: Anders Hamsten Per Eriksson Per Tornvall Susanna Boquist Angela Silveira Carl-Göran Ericsson Pia Lundman Christer Ericsson
Topics: Atherosclerosis and Cardiovascular Diseases (10 papers)Adipokines, Inflammation, and Metabolic Diseases (9 papers)Protease and Inhibitor Mechanisms (5 papers)
Cited by: Immunology Hematology Cancer Research
Journals: Circulation Nature Genetics PLoS ONE
Partner nations: Sweden United Kingdom United States

In The Last Decade

Ann Samnegård

27 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ann Samnegård

Since Specialization

Citations

This map shows the geographic impact of Ann Samnegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Samnegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Samnegård more than expected).

Fields of papers citing papers by Ann Samnegård

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Samnegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Samnegård. The network helps show where Ann Samnegård may publish in the future.

Co-authorship network of co-authors of Ann Samnegård

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Samnegård. A scholar is included among the top collaborators of Ann Samnegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Samnegård. Ann Samnegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction 2024 ·Cytokine ·(unknown),Tomas Jernberg,Ann Samnegård,Fredrik Johansson,Angela Silveira,Per Tornvall,Pia Lundman	5
2	A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis 2012 ·Molecular Medicine ·(unknown),(unknown),Eva Sundman,(unknown),О. А. Овчинникова,(unknown),Nikolai Scherbak,Giuseppe Danilo Norata,Ann Samnegård,Hans Törmä,Samy M. Abdel‐Halim,Jan‐Håkan Jansson,Per Eriksson,Allan Sirsjö,Peder S. Olofsson	27
3	Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years 2012 ·Atherosclerosis ·Anna Deleskog,(unknown),Angela Silveira,Ann Samnegård,Per Tornvall,Per Eriksson,Sven A. Gustafsson,Claes‐Göran Östenson,John Öhrvik,Anders Hamsten	23
4	A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction 2011 ·PLoS ONE ·Massimiliano Ria,Jacob Lagercrantz,Ann Samnegård,Susanna Boquist,Anders Hamsten,Per Eriksson	18
5	Plasma CD93 concentration is a potential novel biomarker for coronary artery disease 2011 ·Journal of Internal Medicine ·Anders Mälarstig,Angela Silveira,Dick Wågsäter,John Öhrvik,Alexandra Bäcklund,Ann Samnegård,Mohsen Khademi,Mai-Lis Hellénius,Karin Leander,Tomas Olsson,Mathias Uhlén,Ulf dé Fairé,Per Eriksson,Anders Hamsten	34
6	Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome 2011 ·EuroIntervention ·Jonas Persson,Johan Lindbäck,Claes Hofman‐Bang,Bo Lagerqvist,Ulf Stenestrand,Ann Samnegård	19
7	Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study 2010 ·Journal of Interferon & Cytokine Research ·Marie Bennermo,Margareta Nordin,Pia Lundman,Sofia Boqvist,Claes Held,Ann Samnegård,Carl-Göran Ericsson,Angela Silveira,Anders Hamsten,(unknown),Per Tornvall	34
8	A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development The Interleukin-1.BETA.:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis 2009 ·Circulation Journal ·Peder S. Olofsson,Yuri Sheikine,Kenbugul Jatta,Mehran Ghaderi,Ann Samnegård,Per Eriksson,Allan Sirsjö	53
9	High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction 2008 ·European Heart Journal ·Per Sjögren,Gunilla Nordin Fredrikson,Ann Samnegård,Christer Ericsson,John Öhrvik,Rachel M. Fisher,Jan Nilsson,Anders Hamsten	85
10	Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients 2008 ·Atherosclerosis ·Ann Samnegård,Johannes Hulthe,Angela Silveira,Carl-Göran Ericsson,Anders Hamsten,Per Eriksson	34
11	Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors 2007 ·Journal of Thrombosis and Haemostasis ·Maria Mannila,Rehana Sultana Lovely,Steven C. Kazmierczak,Per Eriksson,Ann Samnegård,David H. Farrell,Anders Hamsten,Angela Silveira	73
12	Lower serum concentration of matrix metalloproteinase‐3 in the acute stage of myocardial infarction 2006 ·Journal of Internal Medicine ·Ann Samnegård,Angela Silveira,Per Tornvall,Anders Hamsten,Christer Ericsson,Per Eriksson	27
13	Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6 2006 ·Atherosclerosis ·Johannes Hulthe,William L. McPheat,Ann Samnegård,Per Tornvall,Anders Hamsten,Per Eriksson	71
14	Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR‐PSOX gene 2005 ·Journal of Internal Medicine ·(unknown),(unknown),Ann Samnegård,Pia Lundman,Per Tornvall,Stefanie Dimmeler,Andreas M. Zeiher,Anders Hamsten,Göran K. Hansson,Per Eriksson	39
15	Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction 2005 ·Journal of Internal Medicine ·Ann Samnegård,Angela Silveira,Pia Lundman,Susanna Boquist,Jacob Odeberg,J. Hulthe,William L. McPheat,Per Tornvall,L. Bergstrand,Christer Ericsson,Anders Hamsten,Per Eriksson	96
16	Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease 2005 ·Atherosclerosis ·Yuri Sheikine,(unknown),Lennart Nilsson,Ann Samnegård,Anders Hamsten,Lena Jonasson,Per Eriksson,Allan Sirsjö	48
17	Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility 2005 ·Nature Genetics ·Xiaosong Wang,Massimiliano Ria,Peter M. Kelmenson,Per Eriksson,David Higgins,Ann Samnegård,(unknown),Jarod Rollins,Anna M. Bennet,Björn Wiman,Ulf dé Fairé,C. Wennberg,Per Olsson,Naoto Ishii,Kazuo Sugamura,Anders Hamsten,Kristina Forsman‐Semb,Jacob Lagercrantz,Beverly Paigen	224
18	Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction 2005 ·Thrombosis and Haemostasis ·Per Eriksson,Pia Lundman,Ann Samnegård,Susanna Boquist,Carl-Göran Ericsson,Per Tornvall,Anders Hamsten,Angela Silveira,Maria Mannila	34
19	A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein 2004 ·Atherosclerosis ·Alexander Kovacs,Fiona Green,Lars‐Olof Hansson,Pia Lundman,Ann Samnegård,Susanna Boquist,Carl-Göran Ericsson,Hugh Watkins,Anders Hamsten,Per Tornvall	106
20	Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans 2004 ·Atherosclerosis ·Ron Korstanje,Per Eriksson,Ann Samnegård,Per Olsson,Kristina Forsman‐Semb,Śaunak Sen,Gary A. Churchill,Jarod Rollins,Stephen Harris,Anders Hamsten,Beverly Paigen	37

About Ann Samnegård

Ann Samnegård is a scholar working on Immunology, Cancer Research and Hematology, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Protease and Inhibitor Mechanisms (5 papers). The work is most often cited by research in Immunology (532 citations), Hematology (187 citations) and Cancer Research (221 citations). Ann Samnegård has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Anders Hamsten, Per Eriksson, Per Tornvall, Susanna Boquist, Angela Silveira, Carl-Göran Ericsson, Pia Lundman, Christer Ericsson, William L. McPheat and Lars‐Olof Hansson. Their work appears in journals such as Circulation, Nature Genetics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact